Floatz logo

Nimodipine

Postictal Delirium

Rijnstate HospitalSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

13 Active assets in the Postictal Delirium cohort.

Asset / SponsorPhaseRating
PROPOFOL
RenJi Hospital
Phase 4BB
ISOFLURANE
Duke University
Phase 4BB
.GAMMA.-CYCLODEXTRIN, 6A,6B,6C,6D,6E,7F,6G,6H-OCTAKIS-S-(2-CARBOXYETHYL)-6A,6B,6C,6D,6E,7F,6G,6H-OCTATHIO-
Konkuk University Medical Center
Phase 4BB
Pyridostigmine
Konkuk University Medical Center
Phase 4BB
Clonidine
Insel Gruppe AG, University Hospital Bern
Phase 4BB

View all 23 →

Same molecule, other indications

Nimodipine is also rated in:

stroke disorderDormant
BB
Indicative ·
68 / 100
View asset →
reversible cerebral vasoconstriction syndromeDormant
BB
Indicative ·
64 / 100
View asset →
cerebral infarctionDormant
B
Indicative ·
63 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →